The Effect of an Inter-Disciplinary Program, Including MBSR, in Breast Cancer Survivors With Chronic Neuropathic Pain
CompletedNot applicableNCT02125006
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
Brief summary (from the registry)
Chronic neuropathic pain is a common problem for breast cancer survivors. Even with the best medical treatment, some survivors continue to experience disabling pain. It is well-established that an interdisciplinary approach is key to the treatment of some types of chronic pain, but little research has been done on the effectiveness of interdisciplinary treatments for cancer survivors with chronic neuropathic pain. The investigators will evaluate the effectiveness of an interdisciplinary approach combining medical treatment and mindfulness-based stress reduction (MBSR) to reduce disability and improve quality of life among breast cancer survivors with chronic neuropathic pain. The investigators will also evaluate the impact of the program on psychological distress, pain cognitions, biomarkers of stress and immune function, cognitive function, as well as brain structure and function.
Study details
- Official title
- The Effect of an Inter-Disciplinary Program, Including Mindfulness-Based Stress Reduction, on Psychosocial Function, Pain Perception, Disability and Quality of Life in Breast Cancer Survivors With Chronic Neuropathic Pain
- Conditions
- Breast Cancer
- Painful Neuropathy
- Chronic Pain
- Worries
- Pain or Disability
- Quality of Life
- Interventions
- Sponsor
- Ottawa Hospital Research Institute
- Collaborators
- Canadian Breast Cancer Foundation; Canadian Institutes of Health Research (CIHR)
- Start date
- 2013-10
- Primary completion
- 2017-10
- Sex
- Female
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Canada
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Female. * 18 years or older. * Completed treatment for breast cancer a minimum of 1 year prior to study enrollment. * Have been experiencing neuropathic pain following their cancer treatment for a minimum of 6 months. * Report pain intensity levels ≥4 (moderate to severe). Exclusion Criteria: * Metastatic disease or current evidence of cancer recurrence * Pregnancy or breastfeeding * Unable to complete questionnaires in English or French.
Canadian sites (1)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02125006